
|Videos|September 20, 2021
Latest Treatment Updates in Cervical Cancer
Pharmacy Times spoke with Dr. Bradley Monk, investigator for KEYNOTE-826, #LBA2, which was presented at the ESMO Congress 2021, about the study and its importance to the world of cervical cancer.
Advertisement
Pharmacy Times spoke with Dr. Bradley Monk, investigator for KEYNOTE-826, #LBA2, which was presented at the ESMO Congress 2021, about the study and its importance to the world of cervical cancer.
Dr. Monk discussed the highlights of the study, limitations and gaps, and what he feels were the most important findings of the study in the interview.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists as the Glue in Cardio-Kidney-Metabolic Care
2
Pharmacists Can Close the LDL Control Gap in Lipid Care
3
Extended-Interval Tarlatamab Dosing Offers Pharmacists More Flexible Administration Windows in SCLC
4
Cancer Among 9/11 Survivors Is Accelerating 25 Years Later
5



































































































